Global Amifostine Market Study 2015-2025, by Segment (400mg/Dose, 500mg/Dose), by Market (Ovarian Cancer Adjuvant Therapy, Head and Neck Cancer Adjuvant Therapy500mg/Dose, Others), by Company (Clinigen Group, Sun Pharmaceutical, Taj Pharmaceuticals)
ReportPage
Report ID
16821
Published Date
06-Oct
No of Report Page
63
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
    
The global Amifostine market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
    
Product Type Coverage (Market Size & Forecast, Major Company of Product Type et
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Amifostine Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Amifostine Market by Type
    
    2.1 By Type
    
       2.1.1 400mg/Dose
    
       2.1.2 500mg/Dose
    
    2.2 Market Size by Type
    
    2.3 Market Forecast by Type
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -